ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Health Services Research"

  • Abstract Number: 0606 • ACR Convergence 2020

    A Systematic Review Exploring Pre-COVID-19 Telehealthcare Models Used in the Management of Patients with Rheumatological Disease

    Alexandra Nelson1 and Marina Anderson2, 1University of Liverpool, Liverpool, United Kingdom, 2Lancaster University, Lancaster, United Kingdom

    Background/Purpose: Recent advancements in the delivery and utilization of information and communication technologies (ICTs) have led to an increased application of telehealthcare services. Global coronavirus…
  • Abstract Number: 1610 • ACR Convergence 2020

    Cutaneous Side Effects of Hydroxychloroquine in Rheumatic Diseases –Combination of “Traditional” Multivariate Analysis for Risk Factors AndClassification Model Development Using Supervised Machine Learning –Single Centre Retrospective Cohort Study in India

    Sandeep Surendran1, Mithun CB1, Arun Tiwari2, Vishal Marwaha1 and Sekhar Easwar1, 1Amrita Institute of Medical Sciences, Kochi, Kerala, India., Kochi, Kerala, India, 2Amrita Institute of Medical Sciences, Kochi, Kerala, India., Kochi, India

    Background/Purpose: Hydroxychloroquine (HCQ) is associated with varied cutaneous side effects but only few studies in literature characterizing the risk factors for this. Recently machine learning…
  • Abstract Number: 0580 • ACR Convergence 2020

    Risk of Severe Acute Localized Reactions for Different Intra-Articular Hyaluronic Acid Knee Injections in a Real World Setting

    Kevin Ong1, Jack Farr2, Louis McIntyre3, Andrew Gudeman2, Iain Murray4, Charles Hummer5, Wilson Ngai6, Heather Good7, Edmund Lau8 and Roy Altman9, 1Exponent, Philadelphia, 2Indiana University Department of Orthopaedic Surgery, Indianapolis, 3US Orthopedics, Tarrytown, 4Department of Orthopaedics, The University of Edinburgh, Edinburgh, United Kingdom, 5Premier Orthopaedics and Sports Medicine, Glen Mills, 6Sanofi US, Bridgewater, 7Sanofi US, Bridgewater, FL, 8Exponent, Menlo Park, 9David Geffen School of Medicine, University of California, Agua Dulce, CA

    Background/Purpose: Case reports of severe acute localized reactions (SALR) following intra-articular (IA) hyaluronic acid (HA) injections for knee osteoarthritis (OA) have been described. These have…
  • Abstract Number: 0608 • ACR Convergence 2020

    Patient and Parent Perspectives in a Academic Pediatric Rheumatology Transition Clinic

    Rebecca Overbury1, Tracy Frech2, John Bohnsack3, CJ Inman1, Sara Stern1, Karen James1, Erin Treemarcki4 and Aimee Hersh4, 1University of Utah and Primary Children's Hospital, Salt Lake City, UT, 2University of Utah and Salt Lake Veterans Affair Medical Center, Salt Lake City, UT, 3University of Utah and Primary Children's Hospital, Cincinnati, OH, 4University of Utah and Primary Children's Hospital, Salt Lake City

    Background/Purpose: In November 2018 we initiated a transition clinic called ACCORD (Adult Center for Childhood Onset Rheumatic Disease). Our unique structure integrates an adult rheumatologist…
  • Abstract Number: 1621 • ACR Convergence 2020

    Cervical Cancer Screening Among Women with Systemic Lupus Erythematosus or Prescribed Tumor Necrosis Alpha-inhibitors Who Receive Outpatient Rheumatology Care

    Mehret Birru Talabi1, Kwonho Jeong1, Kaleab Abebe1, Megan Clowse2, Robyn Domsic3 and Sonya Borrero1, 1University of Pittsburgh, Pittsburgh, PA, 2Duke University, Chapel Hill, NC, 3University of Pittsburgh School of Medicine, Pittsburgh, PA

    Background/Purpose: Cervical cancer screening is important for women with systemic lupus erythematosus (SLE) and women prescribed TNF-alpha inhibitors (TNFi), as they have an increased risk…
  • Abstract Number: 0583 • ACR Convergence 2020

    Cost of Illness in Patients with Psoriasis and Psoriatic Arthritis

    Santos Castañeda1, Esther Francisca Vicente-Rabaneda2, Mar Llamas-Velasco3, Javier Sánchez-Pérez3, José Pardo4, Rita Cabeza-Martínez5, Mercedes Miranda-Fontes6, Juan Márquez7, Jaime Calvo-Alén8, Susana Armesto9, Isabel Belinchón10, Alejandro Gómez11, María Dolores Miranda12, Silvia Martínez-Pardo13, Leticia Merino Melendez14, Miguel Ángel Casado15, María Yébenes15 and Araceli Casado15, 1Princesa University Hospital, Universidad Autónoma, Madrid, Madrid, Spain, 2Hospital Universitario de la Princesa, IIS-Princesa, UAM, Madrid, Madrid, Spain, 3Hospital Universitario de la Princesa, IIS-Princesa, Madrid, Madrid, Spain, 4H.G.U. Santa Lucía, Cartagena, Murcia, Spain, 5H.U. Puerta de Hierro Majadahonda, Madrid, Madrid, Spain, 6H.U. Río Hortega, Valladolid, Valladolid, Castilla y Leon, Spain, 7H.G. Jerez de la Frontera, Cádiz, Andalucia, Spain, 8Hospital Universitario Araba, Vitoria-Gasteiz, Pais Vasco, Spain, 9H.U. Marqués de Valdecilla, Santander, Cantabria, Spain, 10H.G.U. Alicante, Alicante, Comunidad Valenciana, Spain, 11H.U. Infanta Sofía, San Sebastián de los Reyes, Madrid, Spain, 12H.G. San Agustín de Linares, Jaen, Andalucia, Spain, 13H. Mutua de Terrassa, Barcelona, Catalonia, Spain, 14H. San Pedro, Logroño, Spain, 15Pharmacoeconomics & Outcomes Research Iberia (PORIB), Madrid, Madrid, Spain

    Background/Purpose: Psoriasis (Ps) and psoriatic arthritis (PsA) have a major impact on patients’ health-related quality of life. Cost of illness of patients with Ps, PsA and…
  • Abstract Number: 0610 • ACR Convergence 2020

    Change in Utilization of Outpatient Services at US Community Rheumatology Practices During COVID-19 Outbreak

    Kent Kwas Huston1, Nehad Soloman2, Janna Radtchenko3, Simon Helfgott4, Jasvinder Singh5 and Colin Edgerton6, 1Kansas City Physician Partners, Kansas City, MO, 2Arizona Arthritis & Rheumatology Associates, P.C., Peoria, AZ, 3Trio Health, Louisville, CO, 4BWH- HMS, Boston, MA, 5University of Alabama at Birmingham, Birmingham, AL, 6Articularis Healthcare, Summerville, SC

    Background/Purpose: Patients (pts) with autoimmune diseases managed by rheumatologists represent vulnerable population with risk of serious complications if exposed to novel coronavirus SARS-CoV2. The first…
  • Abstract Number: 1684 • ACR Convergence 2020

    Increase in Emergency Department Visits and Hospitalizations, Decrease in Outpatient Visits Following Transition to Adult Rheumatologic Care

    Paul Jensen1, Jessica Greco2, Kenneth Jackson3 and Stacy Ardoin4, 1Intermountain Healthcare, St. George, UT, 2Ohio State University/Nationwide Children's Hospital, Columbus, OH, 3Ohio State University Medical Center, Columbus, OH, 4Nationwide Children's Hospital, Columbus, OH

    Background/Purpose: Many children with rheumatic disease have active disease as adults, and health care gaps often occur in the transition from pediatric to adult care.…
  • Abstract Number: 0587 • ACR Convergence 2020

    Barriers to Rheumatologic Care and Antimalarial Refills Among a Cohort of Patients with Systemic Lupus Erythematosus During the COVID-19 Pandemic

    Alfredo Aguirre1, Laura Trupin1, Sarah Patterson2, Kimberly DeQuattro2, Patricia Katz3, Cristina Lanata2, Stephanie Rush1, Lindsey Criswell4, Maria Dall'Era5 and Jinoos Yazdany1, 1University of California, San Francisco, San Francisco, CA, 2UCSF, San Francisco, CA, 3University of California, San Francisco, Novato, CA, 4Rosalind Russell/Ephraim P. Engleman Rheumatology Research Center, University of California San Francisco, San Francisco, CA, 5Division of Rheumatology, University of California, San Francisco, CA

    Background/Purpose: The pandemic of coronavirus disease 19 (COVID-19) has led to widespread disruptions across the spectrum of healthcare. We sought to investigate barriers to medical…
  • Abstract Number: 0612 • ACR Convergence 2020

    Differences in 30-Day Rehospitalization Risk and Predictors by Age Group Among Patients with Lupus in Medicare

    Maria Schletzbaum1, Yi Chen2, Ann Sheehy3, Farah Kaiksow3, Ryan Powell4, Andrea Gilmore-Bykovskyi5, Amy Kind6 and Christie Bartels7, 1University of Wisconsin-Madison School of Medicine and Public Health, Department of Population Health Sciences, Madison, WI, 2University of Wisconsin School of Medicine and Public Health, Department of Biostatistics and Medical Informatics, Madison, WI, 3University of Wisconsin School of Medicine and Public Health, Department of Medicine, Hospital Medicine Division, Madison, WI, 4University of Wisconsin School of Medicine and Public Health, Department of Medicine, Geriatrics Division, Madison, WI, 5University of Wisconsin - Madison, School of Nursing, Madison, WI, 6University of Wisconsin-Madison School of Medicine and Public Health, Department of Medicine, Health Services and Care Research Program, Geriatrics Division, Madison, WI, 7University of Wisconsin School of Medicine and Public Health, Department of Medicine, Division of Rheumatology, Madison, WI

    Background/Purpose: Although our recent research demonstrates that young adult Medicare beneficiaries (age 18-35) with lupus (SLE) have higher risk of 30-day rehospitalization, predictors specific to…
  • Abstract Number: 1880 • ACR Convergence 2020

    Association of Healthcare Utilization and Costs with Patient-Reported Outcomes in Patients with Ankylosing Spondylitis

    Alexis Ogdie1, Mark Hwang2, Phani Veeranki3, Alexandria Portelli3, Steven Sison3, Jason Shafrin3, Sofia Pedro4, Esther Yi5 and Kaleb Michaud6, 1Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, 2McGovern Medical School at the University of Texas Health Science Center at Houston, Houston, TX, 3PRECISIONheor, Los Angeles, 4FORWARD-The National Data Bank for Rheumatic Diseases, Wichita, 5Novartis Pharmaceuticals Corporation, East Hanover, NJ, 6FORWARD-The National Data Bank for Rheumatic Diseases; University of Nebraska Medical Center, Wichita

    Background/Purpose: Treatments for ankylosing spondylitis (AS) have been shown to improve patient-reported outcome (PRO) measures in clinical studies; however, healthcare decision makers have limited ability…
  • Abstract Number: 0589 • ACR Convergence 2020

    The Ideal Mhealth Application for Rheumatoid Arthritis: Qualitative Findings from Stakeholder Focus Groups

    Diederik De Cock1, Maryline Vandeputte2, Rani Van Melder2, Michael Doumen2, Delphine Bertrand1, Veerle Stouten1, Sofia Pazmino1, Rene Westhovens3 and Patrick Verschueren4, 1KU Leuven, Leuven, Belgium, 2KU Leuven, Leuven, 3University Hospitals Leuven, Belgium, Leuven, Belgium, 4University Hospital Leuven, Leuven, Belgium

    Background/Purpose: Early access to specialized rheumatological care is under increasing pressure. Many countries are currently confronted with a relative shortage of practicing rheumatologists, while recent…
  • Abstract Number: 0613 • ACR Convergence 2020

    Modeling the Effects of Covid-19 Protective Behaviors and Healthcare Delivery on the Health of Patients with Rheumatic Disease

    Kevin Kennedy1, Emily Sirotich2, Salman Surangiwala3, Maggie Larche2, Mitchell Levine1 and Jonathan Hausmann4, 1McMaster University, Hamilton, Canada, 2McMaster University, Hamilton, ON, Canada, 3Queen’s School of Medicine, Kingston, Canada, 4Boston Children's Hospital / Beth Israel Deaconess Medical Center, Cambridge, MA

    Background/Purpose: COVID-19 has caused global disruptions in the management of chronic illnesses. The extent to which patients with rheumatic disease have been affected by COVID-19…
  • Abstract Number: 1959 • ACR Convergence 2020

    Epidemiology of Hospitalizations and Associated Mortality in Vasculitis: A National Study

    Jasvinder Singh1 and John Cleveland1, 1University of Alabama at Birmingham, Birmingham, AL

    Background/Purpose: To assess whether comorbid diseases frequently associated with primary hospitalizations for non-vasculitis causes in people with vasculitis are changing over time in people with…
  • « Previous Page
  • 1
  • …
  • 16
  • 17
  • 18
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology